Tumor-based pharmacokinetics has greater significance for anticancer drugs than does blood-based pharmacokinetics.
Wolf
Walter
W
Presant
Cary A
CA
D000964:Antimetabolites, Antineoplastic / Q000097:blood / Q000493:pharmacokinetics; D000970:Antineoplastic Agents / Q000097:blood* / Q000493:pharmacokinetics*; D004347:Drug Interactions; D005472:Fluorouracil / Q000097:blood / Q000493:pharmacokinetics; D006801:Humans; D009369:Neoplasms / Q000737:chemistry* / Q000378:metabolism*; D009944:Organoplatinum Compounds / Q000009:adverse effects; D000077150:Oxaliplatin
D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D005472:Fluorouracil